Información del producto
- b-D-Glucopyranoside, (3b,4a,18b,19S,20S)-19,28-epoxy-23-(b-D-glucopyranosyloxy)-18,29-dihydroxy-18,19-secolupan-3-yl 2-O-b-D-glucopyranosyl-
- 18,19-Secolupane, b-D-glucopyranoside deriv.
- Spiro[chrysene-2(1H),3'(4'H)-[2H]pyran], b-D-glucopyranoside deriv.
- b-D-Glucopyranoside,[[1R,2S-[S-(S)],4aR,4bR,6aR,7R,8S,10aR,10bR,12aS]-8-[(2-O-b-D-glucopyranosyl-b-D-glucopyranosyl)oxy]octadecahydro-1-hydroxy-6'-(2-hydroxy-1-methylethyl)-4a,4b,7,10a-tetramethylspiro[chrysene-2(1H),3'(4'H)-[2H]pyran]-7-yl]methyl
Hosenkoside A is a saponin that has been used in health care products. It has shown potent cytotoxic activity against malignant melanoma cells, du145, and colorectal adenocarcinoma cells. The cytotoxicity of Hosenkoside A may be due to its ability to cause cell death through the induction of apoptosis. Hosenkoside A also inhibits the production of enzymes involved in polyamine synthesis, which are required for DNA replication and cell division. Hosenkoside A has been shown to inhibit the growth of prostate cancer cells by inhibiting protein synthesis. Hosenkoside A can be detected using mass spectrometric detection or bioassay.